Thailand Anti-obesity Medication Market Size & Outlook

The anti-obesity medication market in Thailand is expected to reach a projected revenue of US$ 546.0 million by 2030. A compound annual growth rate of 45.8% is expected of Thailand anti-obesity medication market from 2024 to 2030.
Revenue, 2023 (US$M)
$38.9
Forecast, 2030 (US$M)
$546.0
CAGR, 2024 - 2030
45.8%
Report Coverage
Thailand

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Thailand anti-obesity medication market, 2018-2030 (US$M)

Thailand anti-obesity medication market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Thailand Anti-obesity Medication Market Insights

  • The Thailand anti-obesity medication market generated a revenue of USD 89.7 million in 2024.
  • The market is anticipated to grow at a CAGR of 35.1% from 2025 to 2030.
  • In terms of segment, approved was the largest segment in 2024.
  • Approved is the most lucrative product segment registering the fastest growth during the forecast period.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Anti-obesity Medication Market Scope

Anti-obesity Medication Market Companies

Name Profile # Employees HQ Website
Gelesis View profile 11-50 Boston, Massachusetts, United States, North America http://www.gelesis.com
Kintai Therapeutics View profile 1-10 Cambridge, Massachusetts, United States, North America https://www.kintaitx.com/
Currax Pharmaceuticals View profile 101-250 Morristown, New Jersey, United States, North America http://www.curraxpharma.com/
VIVUS View profile 51-100 Mountain View, California, United States, North America http://www.vivus.com
Boehringer Ingelheim International GmbH View profile - - -
Rhythm Pharmaceuticals Inc View profile 226 222 Berkeley Street, 12th Floor, Boston, MA, United States, 02116 http://www.rhythmtx.com
Icahn Enterprises LP Depositary Units Repr Units of LP Interests View profile 15038 16690 Collins Avenue, PH-1, Penthouse Suite, Sunny Isles Beach, FL, United States, 33160 https://www.ielp.com
GlaxoSmithKline View profile 10001+ London, England, United Kingdom, Europe http://www.gsk.com
PureTech Health PLC View profile 90 6 Tide Street, Suite 400, Boston, MA, United States, 02210 https://www.puretechhealth.com
Novo Nordisk A/S ADR View profile 66015 Novo Alle 1, Bagsvaerd, Denmark, 2880 https://www.novonordisk.com
Novartis AG ADR View profile 76057 Lichtstrasse 35, Basel, Switzerland, 4056 https://www.novartis.com

Thailand anti-obesity medication market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anti-obesity medication market will help companies and investors design strategic landscapes.


Reasons to subscribe to Thailand anti-obesity medication market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Thailand anti-obesity medication market databook

  • Our clientele includes a mix of anti-obesity medication market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Thailand anti-obesity medication market , including forecasts for subscribers. This country databook contains high-level insights into Thailand anti-obesity medication market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Thailand Anti-obesity Medication Market Outlook Share, 2023 & 2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online